Health care-associated native valve endocarditis: importance of non-nosocomial acquisition.
about
HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohortFuture challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSACatheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative reviewInfective endocarditis involving an apparently structurally normal valve: new epidemiological trend?Infective endocarditis epidemiology over five decades: a systematic reviewStructures of Helicobacter pylori Shikimate Kinase Reveal a Selective Inhibitor-Induced-Fit MechanismInfective endocarditis in the U.S., 1998-2009: a nationwide studyThe Changing Epidemiology of Infective Endocarditis in the Twenty-First Century.Managing infective endocarditis in the elderly: new issues for an old disease.Bacteraemia in haemodialysis patients--not always Staphylococcus aureus.Mechanisms of infective endocarditis: pathogen-host interaction and risk states.Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota.Comparison of the clinical features and outcomes of infective endocarditis between hemodialysis and non-hemodialysis patients.Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system.Non-nosocomial healthcare-associated infective endocarditis in Taiwan: an underrecognized disease with poor outcomeEvaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia.Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus.Healthcare-associated infective endocarditis: a case series in a referral hospital from 2006 to 2011.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Profile of infective endocarditis observed from 2003 - 2010 in a single center in Italy.Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography.Classification of healthcare-associated infection: a systematic review 10 years after the first proposalUse of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremiaImpact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study.Management of neurological complications of infective endocarditis in ICU patientsInfective endocarditis in the Pacific: clinical characteristics, treatment and long-term outcomes.Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration.Enterococcal endocarditis: can we win the war?Microbiology of healthcare-associated infections and the definition accuracy to predict infection by potentially drug resistant pathogens: a systematic review.Epidemiology and the prognosis of healthcare-associated infective endocarditis in China: the significance of non-nosocomial acquisition.Non-nosocomial healthcare-associated left-sided Pseudomonas aeruginosa endocarditis: a case report and literature review.Streptococcus sanguinis induces neutrophil cell death by production of hydrogen peroxide.Simplified risk stratification criteria for identification of patients with MRSA bacteremia at low risk of infective endocarditis: implications for avoiding routine transesophageal echocardiography in MRSA bacteremia.Validated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis.Molecular mechanisms of Staphylococcus aureus iron acquisition.Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis.Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study.Treatment strategies for infective endocarditis.
P2860
Q21090758-7E364B75-DEB4-412A-A14B-C71DFDEFF569Q22305769-9F17EA88-B2C8-420E-87C2-1F2B9BA18E87Q26751691-B976D254-87EE-422D-A97C-C869F6E49B17Q26801715-3DD54AA5-A998-4AFF-804E-4EFF8E622AC2Q27024815-5477D187-9BC9-48F5-A91B-72F0EC322ABEQ27678149-83645680-ED62-4330-8FC7-30E0667DFD42Q28488404-83790C06-8665-475A-A7B6-FEDD93638D52Q30234842-0486CA03-F46C-4E3F-B19F-145F0B3D1228Q30245399-FF62AA66-26CD-40AB-8001-6D08C941C320Q30316474-F8239CB6-455F-48E7-B4D2-8590C0283B70Q30317657-EA44AEE7-8635-4BA7-B886-0397A2291537Q33570041-B6B84E6C-D907-42E5-93F5-D0908514EA66Q33739826-C1033484-A394-4173-BF9A-A8A6B563326BQ33827567-D2EC91EE-3463-42C8-B3AC-4C4E75835B45Q33995221-823A1712-B9C5-4F04-A74E-A5F3B7BAC8B9Q34058222-037287FE-31F7-4100-A332-373A77E53976Q34120484-1DDECE40-EE33-460C-B9DF-FD2F1AA8232FQ34343212-0B5B92E8-C358-4B2E-9778-8489A1192EC1Q34387826-98AD11EF-576F-4068-8819-6963517E7DB8Q34478074-B8E901E6-C967-449A-8C46-3138FE379B46Q34478172-CAE3059B-FADD-4D36-A0B9-B288039CD8C7Q35052124-EA37C4DA-D9BF-4B42-8E68-C677FEB7AEBDQ35111689-0A08E414-1B98-4EC7-8FAC-FCD6FBB74759Q35144554-77246C46-A087-42D4-961B-667DC68C954AQ35197262-20958082-E1C9-4770-8F86-DFA50BA49D03Q35574047-A15A0269-6DA4-4A50-8219-B5DEC0FA0E32Q35578431-2FC84779-84BB-43CF-8F10-661F1A08BC44Q35593072-11C3AD2E-94C4-438A-8113-B0A31A6A7D20Q35610638-E8408202-6567-40D1-AE77-A7C772D30151Q35865273-32C11405-0DEE-4141-9C07-05A5E4B86E44Q35909550-743B78D1-62F7-4515-8583-6D9C39837ED1Q36108306-1F72C96E-49E8-4DBD-AB1B-A5572D7F4DA9Q36286251-4D9D58FE-67A8-4E6D-B6C7-A16F7A64CF76Q36494439-70B54B30-FB38-431D-8F1A-A6F9F4F22849Q36877245-3916E4B5-8330-4DF8-ABDB-87118E26A2D4Q37254091-96818A76-DD03-45C8-8665-6F23C633E561Q37270240-DE163442-BBA5-4486-98EF-315DB0679564Q37286911-6160F571-DFB1-4823-B4BF-73836937A1EEQ37598035-870F5E18-6FAE-4396-9E21-5A74EE3642F6Q37681564-DE4A2814-DF2E-4078-82C9-A3BAF53FD1BA
P2860
Health care-associated native valve endocarditis: importance of non-nosocomial acquisition.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Health care-associated native ...... of non-nosocomial acquisition.
@ast
Health care-associated native ...... of non-nosocomial acquisition.
@en
type
label
Health care-associated native ...... of non-nosocomial acquisition.
@ast
Health care-associated native ...... of non-nosocomial acquisition.
@en
prefLabel
Health care-associated native ...... of non-nosocomial acquisition.
@ast
Health care-associated native ...... of non-nosocomial acquisition.
@en
P2093
P2860
P50
P1476
Health care-associated native ...... of non-nosocomial acquisition.
@en
P2093
A Sampath Kumar
Ana del Río
Asuncion Moreno
Christopher H Cabell
Francisco M Nacinovich
Francois Delahaye
Fredy Suter
Helen Giamarellou
ICE-PCS (International Collabo ...... ve Cohort Study) Investigators
Javier Altclas
P2860
P304
P356
10.7326/0003-4819-150-9-200905050-00004
P407
P50
P577
2009-05-01T00:00:00Z